Management Team-Guangzhou DiQi Pharmaceuticals Co., Ltd

Frank LiuPhD/MBA, General Manager

Comprehensive work, Formulation development and industrialization

Professional Titles & Affiliations:‌Deputy Director‌, Pharmaceutical Preparation Specialty Committee and Pharmaceutical Excipients Specialty Committee, Guangdong Pharmaceutical Association; ‌Drug Registration and Review Expert‌, Guangdong Provincial Medical Products Administration (GDMPA); ‌Master's Supervisor‌ (Bioengineering), South China University of Technology (SCUT).

‌Experience & Expertise:‌
Possesses ‌over 30 years of experience‌ in pharmaceutical formulation R&D, industrialization, and enterprise management ‌in both the US and China‌.‌ Specializes in the development and industrialization of complex drug delivery systems‌, including: sustained/controlled release formulations, nanoformulations, long-acting injectables (LAI), delivery carriers/vectors.‌ Expertise in the design, development, and industrialization of biodegradable excipients for long-acting formulations.‌ Key achievements include:globally pioneering development and industrialization of ReGel®‌, a thermosensitive biodegradable hydrogel. Development and industrialization of copolymers: ‌mPEG-PLLA‌ (methoxy polyethylene glycol-poly(L-lactic acid)), ‌PLGA‌ (poly(lactic-co-glycolic acid)), ‌mPEG-PLGA‌, and ‌PLGA-PEG-PLGA‌.

‌Product Development Track Record:‌
Has ‌led or contributed to the development of over 30 commercialized products‌ and ‌over 10 clinical-stage products‌. Notable examples include: ‌globally pioneering development of Paclitaxel Nanomicelles‌ (marketed in the EU and South Korea; phase III clinical trials in the US).‌Development and industrialization of OncoGel®‌, the ‌world's first Paclitaxel-loaded thermosensitive hydrogel‌ (phase III clinical trials in the US).‌Globally pioneering development and industrialization of a sustained-release tablet for heart failure (anti-HF)‌ (class I Innovative Drug; phase III clinical trials).

Ling ZhangExecutive Vice General Manager

Financing, Administrative management, BD

Years of experience in pharmaceutical marketing, having founded two companies, possessing rich entrepreneurial and administrative management experience, as well as strong public relations coordination and market development abilities.
Tang-Sheng Peng PhD, Vice General Manager

Quality management, Pharmaceutical administration

More than 30 years of experience in pharmaceutical administration, quality control, and drug analysis in the United States; Formerly served as the Director of Analysis, Vice President of Quality, and Director of Pharmaceutical Administration for several pharmaceutical companies; Guide multiple domestic and foreign pharmaceutical companies to obtain FDA and EU certifications. Assisted multiple international companies in applying for dozens of new and generic drugs.
Dihua JinPhD, Vice General Manager

Pharmaceutical Analysis

More than 30 years of experience in drug analysis between the United States and China, particularly in the fields of sustained-release formulations and inhalation administration. I have rich experience in method development, validation, transfer, establishment of quality standards, GMP laboratory management, and other aspects. Led and participated in the development of over ten marketed products, which were filed in China, Europe and the United States. Previously worked at Huahai Pharmaceutical, 3M, Merck, and Anchen (now ParPharmaceuticals).